» Articles » PMID: 29258496

Teaching Young GPs to Cope with Psychosocial Consultations Without Prescribing: a Durable Impact of an E-module on Determinants of Benzodiazepines Prescribing

Overview
Journal BMC Med Educ
Publisher Biomed Central
Specialty Medical Education
Date 2017 Dec 21
PMID 29258496
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite guidelines and campaigns to change prescribing behavior, General Practitioners (GPs) continue to overprescribe benzodiazepines (BZDs). New approaches to improve prescribing are needed. Using behavior change techniques and tailoring interventions to user characteristics are vital to promote behavior change. This study evaluated the impact of an e-module on factors known to determine BZD prescribing practice.

Methods: A tailored e-module that focuses on avoiding initial BZD prescriptions (and using psychological interventions as an alternative) was developed and offered to GPs in vocational training. Three self-report assessments took place: at baseline, immediately after the module (short term) and at least six months after completion (long term). Assessed determinants include GPs' attitudes concerning treatment options, perceptions of the patient and self-efficacy beliefs. Readiness to adhere to prescribing guidelines was evaluated through assessing motivation, self-efficacy and implementability of non-pharmacological interventions. Changes in determinants were analyzed using the Wilcoxon signed-rank test. Changes in readiness to adhere to guidelines was analyzed using the nonparametric McNemar Bowker test.

Results: A desirable, significant and durable impact on determinants of BZD prescribing was observed. GPs (n = 121) underwent desirable changes in their attitudes, perceptions and self-efficacy beliefs and these changes remained significant months after the intervention. Barriers to using a non-pharmacological approach often cited in literature remained absent and were not highlighted by the intervention. Furthermore a significant impact on GPs' readiness to adhere to guidelines was observed. Participants reported change in their ability to cope with psychosocial consultations and to have tried using non-pharmacological interventions.

Conclusions: Tailoring an e-intervention to target group (GPs) characteristics appears to be successful in promoting behavioral change in GPs undertaking vocational training. Significant and lasting changes were observed in determinants of prescribing BZDs. The e-intervention resulted in a positive impact on participants' readiness to adhere to BZD prescribing guidance and their coping with psychosocial consultations. Investigating which mechanisms of change are responsible for the observed effectiveness could help to refine and improve future interventions.

Citing Articles

Management of sleep disorder by preceptors in a family medicine residency program in Calgary, Alberta: a mixed-methods study.

Cheung S, OBeirne M, Hill T, Huyghebaert T, Keller S, Kelly M CMAJ Open. 2023; 11(4):E637-E644.

PMID: 37491048 PMC: 10374247. DOI: 10.9778/cmajo.20220080.


The Characteristics of Benzodiazepine Prescribing in the Republic of Srpska, Bosnia and Herzegovina.

Maksimovic Z, Stajic M, Stojiljkovic M, Stoisavljevic Satara S, Stojakovic N, Skrbic R Medicina (Kaunas). 2022; 58(8).

PMID: 35893095 PMC: 9332377. DOI: 10.3390/medicina58080980.


Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior.

Laforgue E, Istvan M, Schreck B, Mainguy M, Jolliet P, Grall-Bronnec M J Clin Med. 2022; 11(8).

PMID: 35456269 PMC: 9032177. DOI: 10.3390/jcm11082176.


Instant Gratification as a Method to Promote Physician Practice Guideline Adherence: A Systematic Review.

Deo N, Johnson E, Kancharla K, OHoro J, Kashyap R Cureus. 2020; 12(7):e9381.

PMID: 32850248 PMC: 7445093. DOI: 10.7759/cureus.9381.


Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review.

Gentile G, Lapeyre-Mestre M, Micallef J BJGP Open. 2020; 4(1).

PMID: 32127364 PMC: 7330199. DOI: 10.3399/bjgpopen20X101014.


References
1.
Holbrook A, Crowther R, Lotter A, Cheng C, King D . Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000; 162(2):225-33. PMC: 1232276. View

2.
Matthys J, Elwyn G, van Nuland M, Van Maele G, De Sutter A, De Meyere M . Patients' ideas, concerns, and expectations (ICE) in general practice: impact on prescribing. Br J Gen Pract. 2008; 59(558):29-36. PMC: 2605528. DOI: 10.3399/bjgp09X394833. View

3.
Davy Z, Middlemass J, Siriwardena A . Patients' and clinicians' experiences and perceptions of the primary care management of insomnia: qualitative study. Health Expect. 2013; 18(5):1371-83. PMC: 5060832. DOI: 10.1111/hex.12119. View

4.
Zubin J, Spring B . Vulnerability--a new view of schizophrenia. J Abnorm Psychol. 1977; 86(2):103-26. DOI: 10.1037//0021-843x.86.2.103. View

5.
Lader M . Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eur Neuropsychopharmacol. 2000; 9 Suppl 6:S399-405. DOI: 10.1016/s0924-977x(99)00051-6. View